Hematopoietic neoplasms of mice have long been used as models of human malignancies even though histologic and pathogenetic parallels have often been less than well established. In mice, high level expression of murine leukemia viruses (MuLV) from germline endogenous ecotropic viruses is associated in some strains (AKR, C58) with development of thymic T cell lymphomas in almost all mice. Remarkably, high-level virus expression from the same loci but on a different genetic background (NFS congenics, termed NFS.V+) is associated with an 80% incidence of B cell lineage lymphomas. T cell lymphomas are associated with the development of pathogenic recombinant mink cell focus- inducing (MCF) viruses while MCF viruses formed during the process of B cell transformation appear to be non-pathogenic. Histologic, phenotypic and molecular characterization of these mouse B lymphomas showed that some are strikingly similar to subsets of non-Hodgkin lymphomas (NHL) of humans but that other subsets of NHL do not appear to occur spontaneously in mice. Understandings of the molecular pathogenesis of human NHL have been advanced by the uncovering of links between cytogenetic aberrations, primarily translocations effecting activation of oncogenes - and histopathologic and immunophenotypic presentations of specific tumor types. Studies of mice have linked proviral insertional mutagenesis rather than translocations of oncogenes with lymphomas but associations of particular integration sites with specific subtypes have not been described. Studies in LIP have advanced opportunities to relate the pathogenesis of mouse and human lymphomas by defining parallels among small lymphocytic, marginal zone (MZL) and subsets of diffuse large cell lymphomas (DLCL). These lymphoma types were observed in both NFS.V+ and AKXD recombinant inbred strains but in differing proportions. One subset of DLCL was found to exhibit translocations involving BCL6, a gene implicated in the development of human DLCL. Another subset was characterized by the presence of high proportions of histiocytes providing a homologue for human histiocyte rich DLCL. All lymphoma types seen in NFS.V+ mice were also seen in virus-negative segregants from a cross with NFS but with longer latencies. Ecotropic virus expression thus seems to act to accelerate the appearance of lymphomas on the NFS background. The importance and potential complexities involved in unraveling the role of MuLV in lymphomagenesis were further highlighted in a study of proviral integrations in lymphomas of AKXD and NFS congenic mice that identified more than a hundred new common integration sites and a series of putative proto-oncogenes. Correlations of histologic, phenotypic and molecular characteristics of mouse leukemias and lymphomas permitteed the development of a consensus nomenclature for these malignancies. These classification systems will privide the foundation for further studies of spontaneous diseases and those modeled through the use of transgenic and knockout mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000858-04
Application #
6809085
Study Section
(LIP)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Kovalchuk, Alexander L; duBois, Wendy; Mushinski, Elizabeth et al. (2007) AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements. J Exp Med 204:2989-3001
Qi, Chen-Feng; Zhou, Jeff X; Lee, Chang Hoon et al. (2007) Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. Cancer Res 67:2439-47
Castillo, Andrew; Morse 3rd, Herbert C; Godfrey, Virginia L et al. (2007) Overexpression of Eg5 causes genomic instability and tumor formation in mice. Cancer Res 67:10138-47
Woo, Y; Wright, S M; Maas, S A et al. (2007) The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity. Oncogene 26:6010-20
Shen, Rhine R; Ferguson, David O; Renard, Mathilde et al. (2006) Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation. Blood 108:1991-8
Calpe, Silvia; Erdos, Erika; Liao, Gongxian et al. (2006) Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters. Immunogenetics 58:15-25
Mattei, Fabrizio; Schiavoni, Giovanna; Borghi, Paola et al. (2006) ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells. Blood 108:609-17
Ponomarenko, Natalia A; Durova, Oxana M; Vorobiev, Ivan I et al. (2006) Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A 103:281-6
Ponomarenko, Natalia A; Durova, Oxana M; Vorobiev, Ivan I et al. (2006) Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale. Immunol Lett 103:45-50
Hao, Xingpei; Shin, Min Sun; Zhou, Jeff X et al. (2006) Histologic and molecular characterizations of megakaryocytic leukemia in mice. Leuk Res 30:397-406

Showing the most recent 10 out of 52 publications